BE1001842A3 - Composition orale a base de potassium et de magnesium et son utilisation. - Google Patents

Composition orale a base de potassium et de magnesium et son utilisation. Download PDF

Info

Publication number
BE1001842A3
BE1001842A3 BE8801017A BE8801017A BE1001842A3 BE 1001842 A3 BE1001842 A3 BE 1001842A3 BE 8801017 A BE8801017 A BE 8801017A BE 8801017 A BE8801017 A BE 8801017A BE 1001842 A3 BE1001842 A3 BE 1001842A3
Authority
BE
Belgium
Prior art keywords
potassium
magnesium
bioavailable
milliequivalents
sep
Prior art date
Application number
BE8801017A
Other languages
English (en)
French (fr)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of BE1001842A3 publication Critical patent/BE1001842A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE8801017A 1987-09-11 1988-09-06 Composition orale a base de potassium et de magnesium et son utilisation. BE1001842A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11

Publications (1)

Publication Number Publication Date
BE1001842A3 true BE1001842A3 (fr) 1990-03-20

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8801017A BE1001842A3 (fr) 1987-09-11 1988-09-06 Composition orale a base de potassium et de magnesium et son utilisation.

Country Status (12)

Country Link
JP (1) JPH01100128A (da)
AU (1) AU619481B2 (da)
BE (1) BE1001842A3 (da)
CH (1) CH677612A5 (da)
DE (1) DE3830563A1 (da)
DK (1) DK501288A (da)
FR (1) FR2620334A1 (da)
GB (1) GB2209668B (da)
IT (1) IT1227010B (da)
LU (1) LU87331A1 (da)
NL (1) NL8802224A (da)
SE (1) SE8803125L (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (en) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Potassium-supplementing preparation
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (fi) * 1991-03-01 1992-09-02 Slk Marketing Oy Dryckpulver.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
CN1090483C (zh) * 1997-07-31 2002-09-11 谢理峰 钾镁缓释片及生产方法
DE10158286B4 (de) * 2000-11-20 2007-08-02 Dehn, Michael C. Wirkstoffspeicherndes Schichtmaterial
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
ATE485814T1 (de) * 2005-08-19 2010-11-15 Verla Pharm Magnesium-mikrotabletten mit verzögerter freisetzung

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2279414A1 (fr) * 1974-07-26 1976-02-20 Smith Kline French Lab Composition pharmaceutique comprenant des composes de magnesium et de potassium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2279414A1 (fr) * 1974-07-26 1976-02-20 Smith Kline French Lab Composition pharmaceutique comprenant des composes de magnesium et de potassium

Also Published As

Publication number Publication date
AU619481B2 (en) 1992-01-30
LU87331A1 (fr) 1989-10-26
GB2209668B (en) 1991-06-05
GB2209668A (en) 1989-05-24
DK501288D0 (da) 1988-09-09
DK501288A (da) 1989-03-12
DE3830563A1 (de) 1989-03-30
IT1227010B (it) 1991-03-05
SE8803125D0 (sv) 1988-09-06
CH677612A5 (da) 1991-06-14
AU2204388A (en) 1989-03-16
SE8803125L (sv) 1989-03-12
IT8848327A0 (it) 1988-09-08
GB8821056D0 (en) 1988-10-05
FR2620334A1 (fr) 1989-03-17
JPH01100128A (ja) 1989-04-18
NL8802224A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
BE1000434A5 (fr) Supplement dietetique a plusieurs vitamines et plusieurs mineraux contenant du fer biodisponible a liberation controlee.
US5238686A (en) Sustained-release pharmaceutical preparation
JP2740993B2 (ja) 内服用新規医薬製剤
EP0385846B1 (fr) Composition pharmaceutique à libération prolongée d'acide valproîque
DE69825165T2 (de) Arzneimittelform mit zwei überzugs-schichten
BE1001842A3 (fr) Composition orale a base de potassium et de magnesium et son utilisation.
US20130189356A1 (en) Pellet formulation for the treatment of the intestinal tract
BE1015217A5 (da)
JP2000514101A (ja) セルトラリン塩及びセルトラリンの持続性剤形
JP2001522876A (ja) 低温コーティング
EP1524969A2 (fr) Microcapsules a liberation modifiee de principes actifs peu solubles pour administration per os
HU229048B1 (hu) 1-Fenil-3-dimetil-amino-propán-vegyületek gyógyászati sói
FR2949061A1 (fr) Microgranules flottants
JPH0625064B2 (ja) 制御放出塩化カリウム
US5468503A (en) Oral pharmaceutical preparation released at infragastrointestinal tract
US4954349A (en) Oral magnesium and potassium compositions and use
US20230263740A1 (en) Capsule for treating ulcerative colitis
FR2540727A1 (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension
JP3759949B2 (ja) 遮光剤及び皮膜組成物
EP0445156B1 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
JPH04264022A (ja) 下部消化管放出型経口製剤
FR2677546A1 (fr) Composition therapeutique pour liberation prolonge de magnesium.
CN102512394B (zh) 一种硝苯地平缓释片及其制备工艺
JPH01224311A (ja) 胃内滞留生の浮遊顆粒の製法

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA-GEIGY A.G.

Effective date: 19920930